Differences in CD14 and α-naphthyl acetate esterase positivity and relation to prognosis in AML
- 1 January 1998
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 22 (1) , 25-30
- https://doi.org/10.1016/s0145-2126(97)00100-8
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Monoclonal antibodies in the management of acute leukemiaAmerican Journal of Hematology, 1995
- Prognostic value of immunophenotyping in acute myeloid leukemia. Australian Leukaemia Study GroupBlood, 1994
- CD14: Cell surface receptor and differentiation markerImmunology Today, 1993
- Role of blast cell immunophenotyping for the diagnosis and prognosis of acute myeloid leukemiaHematological Oncology, 1992
- Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML‐MO)British Journal of Haematology, 1991
- Current concerns in haematology. 2: Classification of acute leukaemia.Journal of Clinical Pathology, 1990
- Diagnostic and prognostic factors in acute monocytic leukaemia: an analysis of 51 casesBritish Journal of Haematology, 1988
- Expression of myelomonocytic antigens on chronic lymphocytic leukemia B cells correlates with their ability to produce interleukin 1Blood, 1987
- Proposed Revised Criteria for the Classification of Acute Myeloid LeukemiaAnnals of Internal Medicine, 1985
- Criteria for the Diagnosis of Acute Leukemia of Megakaryocyte Lineage (M7)Annals of Internal Medicine, 1985